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ischemia is frequent in ESRD patients and is a major predictor of mortality.
Interestingly the incidence of significant coronary stenosis (>70%) is low
when coronary angiography is performed suggesting other mechanisms such
as myocardial microvascular disease (MMD).
We are conducting a prospective observational study (NCT01291771)
evaluating the incidence of major adverse cardiac events (MACE) in ESRD
patients with proven MMD and no history of coronary disease. 105 patients
with positive test for myocardial ischemia will be explored by coronary angi-
ography. Detection of MMD will be performed simultaneously with a pressure
sensor/thermistor-tipped guidewire in the left anterior descending (LAD), the
left circumflex (LCX) and the right coronary artery (RCA). We will measure
Fractional Flow Reserve (FFR) and Coronary Flow Reserve (CFR) allowing
calculation of the Index of Microcirculatory Resistance (IMR). These patients
will be compared in a 2 years follow-up for the incidence of MACE with 105
ESRD patients without myocardial ischemia on non invasive testing. 
We are reporting the preliminary data of patients (n=6) in whom invasive
MMD evaluation was performed. Mean age 63±8 years, sex ratio=1, diabetic
nephropathy=1, under dialysis=4. 1 patient had significant coronary stenosis,
the others had normal angiograms (32%) or non-significant coronary atheroma
(50%). In patients without significant coronary stenosis, mean FFR was
0.93±0.02 (LAD), 0.98±0.02 (LCX) and 0.95±0.02 (RCA). Mean CFR was
3.3±2.7 (LAD), 2.3±1.1 (LCX) and 3.1±1.4 (RCA). Mean IMR was 19±6
(LAD), 27±15 (LCX) and 30±26 (RCA).
Preliminary data suggest impaired myocardial microvascular function in
ESRD patients with positive test for myocardial ischemia and non significant
coronary artery stenosis.
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Objectives: The aim of this investigation was to test the diagnostic addi-
tive value of the C-Terminal Provasopressin (Copeptin) an indirect marker for
arginin-vasopressin (AVP) in the detection of STEMI patients presenting early
(<6 hours after the Symptom Onset (SO). 
Methods: We measured plasma copeptin in 464 consecutive STEMI
patients (78% men, mean age 63 ± 14 years) immediately after the sheath
insertion and before the primary PCI. Of those patients 200 (43.1%) had a
blood sampling early after SO (<6 hours) and were included in this analysis.
Using the previously established threshold of 4.8pmol/L for copeptin and the
local 99th of the upper limit of the normal value for troponin I (0.15μg/L) we
evaluated the additive value of the combination of copeptin and troponin I in
this AMI patients. 
Results: In the 200 Early STEMI presenters, the median time between SO
and blood sample was 165 minutes; IQR [125-230], (min 35-max 360). The
median value of Troponin I at sheath insertion was 0.59 μg/L; IQR [0.13-3.2]
and 33.1 pmol/L, IQR [11.6-111] for copeptin. Troponin I was negative at
admission in n=56 (28%) STEMI patients and copeptin was negative at admis-
sion in n=54 (27%) STEMI patients. Patients with one or two negative bio-
markers presented earlier than those with both positive biomarker (median
time in minutes 152 [127-218] vs. 180 [125-240]). Among the n=56 patients
with a negative troponin value at admission, n=38 (67.8%) had a positive
copeptin value (>4.8pmol/L).
Therefore, when copeptin is combined to troponin I, the proportion of
STEMI patients non-detected was reduced from 28% to a remaining 9.2%
(p<0.001) of very early presenters (median time of 145 min IQR [116-180]).
Conclusions: The combination of copeptin and troponin improves the
diagnostic value in AMI patients but cannot rule out the diagnosis of acute
STEMI in very early presenters (<3 hours).
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Introduction: Paraoxonases (PONs) are closely related antioxidant
enzymes encoded by clustered genes on chromosome 7q. Two particular poly-
morphisms, namely PON1-192 and PON2-311, in the genes encoding the anti-
oxidant enzymes paraoxonase-1 (PON1) and paraoxonase-2 (PON2) have
been associated with an increased risk of acute myocardial infarction (AMI).
However, previous findings have been contradictory. We evaluated three PON
polymorphisms (PON1 Leu55Met and Gln192Arg; PON2 Ser311Cys) in
Tunisian patients with AMI.
Methods: 168 AMI patients compared to 169 healthy volunteers.
Results: PONs allele and genotype frequencies did not differ between
patients and controls. 
The PON polymorphisms (PON1 Leu55Met and Gln192Arg; PON2
Ser311Cys) were not significantly associated with AMI (p=1.11, p=0.09,
p=1.46 respectively). No significant differences in age, sex, BMI, waist cir-
cumference, total Cholesterol, HDL-C and LDL-C were detected among the
three-genotype subgroups of PON1 Leu55Met, PON1 Gln192Arg and PON2
Ser311Cys in the AMI patients.
Conclusions: The PON1 Leu55Met, PON1 Gln192Arg and PON2 Ser311Cys
polymorphisms are not related to acute myocardial infarction in Tunisian population
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Background and aim: Fourier domain Optical Coherence Tomography
(FD-OCT) is a new imaging modality characterized by a high axial resolution
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(10-15μm), a fast pull-back speed and no need for arterial occlusion. This
technique might be useful for a better identification of in vivo culprit coronary
lesion characteristics. The aim of our study was to assess feasibility and
contribution of OCT in the setting of acute coronary syndrome (ACS). 
Methods: Patients admitted in our center for ACS were included in this
study. FD OCT was performed to the culprit lesion when TIMI 3 flow was
obtained spontaneously or after thrombo-aspiration. The thrombus was
assessed with OCT and compared to histopathology analysis. The markers of
vulnerable plaque (lipid rich core, intra-plaque neo channels and thin fibrous
cap) and the rupture site were also analyzed. 
Results: N=11, patients were included, 6 patients with STEMI and 5
patients with NSTEMI. 8 patients presented with TIMI 0 flow, and were
treated with thrombo-aspiration. The site of plaque rupture was easily identi-
fied in 63% of patients. We were able to successfully analyze the fibrous cap
in 100% of the cases, with excellent inter-operator reproducibility. The mean
minimal thickness of the fibrous cap was of 57μm ±11. Other markers of the
vulnerable plaque were also identified such as lipid rich core (72%) and neo-
channels (63%). White and red thrombus could be identified by OCT and
compared to histopathological analysis.
Conclusion: Our study shows that OCT was feasible in ACS, with 100%
procedural success. This is the first in vivo, human report correlating the
thrombus pattern on OCT with histology. Classical markers of vulnerable
plaque such as thin fibrous cap and lipid rich core were and successfully iden-
tified. Neo-channels were also identified and need further investigation for
their diagnostic and prognostic impact. 
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Achieving TIMI flow 3 during primary angioplasty for acute myocardial
(PAMI) was associated with better left ventricular function and better prog-
nosis. Blush score 2 or 3 was an indicator of reperfusion after angioplasty. The
aim of our study was to identify predictive factors of TIMI flow 3 and Blush
score 2 or 3.
Patients and Methods: Two hundred twenty-eight consecutive primary
angioplasty were performed in our department. Culprit artery patency was
classified according to TIMI (Thrombolysis in Myocardial Infarction). Culprit
artery was considered permeable when TIMI flow was grade 3 and the Blush
score was 2 or 3 following revascularization.
Results: A TIMI flow 3 was obtained in 86%. All these following factors
were not associated with patency of culprit coronary: gender, cardio-vascular
risk factors, location and the culprit artery of AMI, Q wave necrosis, multi-
vessel disease and right ventricular extension.
In univariate analysis, left ventricle ejection fraction over than 45% (p=0.014
for TIMI; p=0.01 for Blush) and regression of ST segment elevation more than
50% (p=0.0001 for TIMI; p=0.0001 for Blush) were associated with better TIMI
flow and Blush score. Anemia (p=0.01 for TIMI; p=0.05 for Blush), left ventric-
ular failure (p=0.0001 for TIMI; p=0.007 for Blush), shock (p=0.004 for TIMI;
p=0.001 for Blush) and residual thrombus (p=0.0001 for TIMI p=0.032 for Blush)
were predictive for slow-flow and Blush score 0 or 1.
In multivariate analysis, regression of ST segment elevation more than
50% was the most important predictive factor of blush score 2 or 3 and espe-
cially of TIMI 3 (TIMI 3: p=0.0001, CI=95%, OR=25 [8-79]; Blush score 2
or 3: p=0.0001, CI=95%, OR=2.8 [1.6-5.1]).
Conclusion: Regression of ST segment elevation was the most important
predictor of TIMI 3 and of Blush score 2 or 3, independently associated with
the other factors.
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Background: Reconstruction of majority of bifurcation lesions can be
achieved with a provisional T technique. Unfortunately restenosis still persists,
especially at the ostium of the side branch in DES era. Increasing the amount of
the same drug at the carena site is associated with a non adaptative response and
a majoration of tissue proliferation, while combination of drugs does not lead to
such results. We considered evaluate a combination of drug in a pilot study.
Method: 15 patients (13 male, 2 female), 64+/–11 years old underwent bifur-
cation reconstruction, via 6F radial route, with provisional T strategy and a good
angiographic result using SES (n=9) and EES (n=6) in the main branch with a
mean stent length of 19.5+/–6.1 mm. Final kissing balloon was achieved in all
cases. No additional stent was needed in the side branch. Lesions included distal
left main (n=5), LAD/diagonal (n=6), CX/ obtuse marginal (n=3), distal right cor-
onary artery (n=1). At the end of the procedure an additional drug delivery was
performed locally, with a 1:1 balloon/artery ratio, using a 20 mm Sequent Please
balloon (DEB), Braun (paclitaxel) in the side branch, with a mean diameter of
2.8+/–0.4 mm delivered at 13.6+/–2.6 atm, proximal dot floating at the edge of the
stent. Additional kissing balloon was performed again to prevent stent deformation
following DEB in the bifurcation, using the previous Sequent Please balloon and
appropriate Maverick balloon (Boston Scientific) in the main branch. Informed
consent was obtained for all patients.
Result: Angiographic success was achieved in all cases with no complica-
tion during hospital phase (death, MI, repeat PTCA, CABG, stent occlusion,
stroke, surgery or transfusion). At 6 months, no event was noted.
Conclusion: Combined local drug delivery SES+DEB or EES+DEB for bifur-
cation lesions is safe and feasible in this short serie. One year results will be pre-
sented. Benefit of this strategy in a large multicentric population should be studied.
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Introduction: The coronary heart disease in diabetic women is often dif-
ferent than that in diabetic men, due to a particular pathophysiology. 
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